NCT03979508 2025-11-12
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
Mayo Clinic
Phase 2 Terminated
Mayo Clinic
Washington University School of Medicine
Medical College and Hospital Kolkata
Symbollon Pharmaceuticals